|
39561373 |
0 |
Todorovski A, Wang TF, Carrier M, et al.
CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease.
Blood Adv. 2024 Nov 19:bloodadvances.2024014430. doi: 10.1182/bloodadvances.2024014430.
|
|
39442625 |
0 |
Anuku D, Carrier M, Le Gal G, et al.
Impact of limited language proficiency on participation in venous thromboembolism research: A retrospective analysis.
J Thromb Haemost. 2024 Oct 21:S1538-7836(24)00562-2. doi: 10.1016/j.jtha.2024.09.014.
|
|
39362177 |
0 |
Shaw JR, Almujalli AA, Xu Y, et al.
Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery.
Thromb Res. 2024 Nov;243:109172. doi: 10.1016/j.thromres.2024.109172. Epub 2024 Sep 24.
|
|
39214564 |
0 |
Khalife R, Burnett AE, Tritschler T, et al.
Practical Prescribing: Direct oral anticoagulants.
BMJ. 2024 Aug 30;386:e079520. doi: 10.1136/bmj-2024-079520.
|
|
38927943 |
0 |
Xu Y, Carrier M, Kimpton M.
Arterial Thrombosis in Patients with Cancer.
Cancers (Basel). 2024 Jun 17;16(12):2238. doi: 10.3390/cancers16122238.
|
|
38733691 |
0 |
Cenat JM, Dromer E, Farahi SMMM, et al.
Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis.
Thromb Res. 2024 May 7;238:197-205. doi: 10.1016/j.thromres.2024.05.007.
|
|
38639617 |
0 |
Xu Y, Shao L, Huang Y, et al.
Evaluating Adverse Reactions of Central Venous Catheter Placement in Patients with AIDS: A Meta-Analysis Approach.
Altern Ther Health Med. 2024 Apr 18:AT10670.
|
|
38559571 |
0 |
de Winter MA, Xu Y, Stacey D, et al.
Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding-"This pill will keep you alive tonight".
Res Pract Thromb Haemost. 2024 Mar 1;8(2):102360. doi: 10.1016/j.rpth.2024.102360. eCollection 2024 Feb.
|
|
38160251 |
0 |
Xu Y, Xu M, Zheng X, et al.
Generation of a Predictive Clinical Model for Isolated Distal Deep Vein Thrombosis (ICMVT) Detection.
Med Sci Monit. 2023 Dec 31;29:e942840. doi: 10.12659/MSM.942840.
|
|
38087414 |
0 |
Uminski K, Xu Y, Zahrai A, et al.
Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review.
Haemophilia. 2023 Dec 12. doi: 10.1111/hae.14906.
|
|
37838240 |
0 |
Campbell AIK, Xu Y, Skeith L, et al.
Racial and Ethnic Disparities in Eligibility for Postpartum Venous Thromboembolism Prophylaxis in the United States.
J Thromb Haemost. 2023 Oct 12:S1538-7836(23)00769-9. doi: 10.1016/j.jtha.2023.10.004.
|
|
37801772 |
0 |
Xu Y, Khan F, Kovacs MJ, et al.
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012.
|
|
37614584 |
0 |
Xu Y, Cole K, Collins E, et al.
Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients: Systematic Review and Meta-Analysis.
JACC CardioOncol. 2023 Jun 27;5(4):520-532. doi: 10.1016/j.jaccao.2023.04.003. eCollection 2023 Aug.
|
|
37517478 |
0 |
Marx CE, Schenker C, Xu Y, et al.
Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort.
J Thromb Haemost. 2023 Jul 28:S1538-7836(23)00577-9. doi: 10.1016/j.jtha.2023.07.015.
|
|
37173706 |
0 |
Zheng HT, Xu Y, Yan XY, et al.
Pediatric hypereosinophilic syndrome associated with liver damage, portal vein, splenic vein and superior mesenteric vein thromboses: a case report.
BMC Pediatr. 2023 May 12;23(1):233. doi: 10.1186/s12887-023-04014-0.
|
|
37001973 |
0 |
You D, Xu Y, Krzyzaniak H, et al.
Safety of expedited-surgery protocols in anticoagulant-treated patients with hip fracture: a systematic review and meta-analysis.
Can J Surg. 2023 Mar 31;66(2):E170-E180. doi: 10.1503/cjs.010021. Print 2023 Mar-Apr.
|
|
36382456 |
0 |
Tang Y, Xu Y, Zhang X, et al.
[Low molecular weight heparin combined with aspirin to prevent perioperative venous thromboembolism in patients with splenic rupture and lower extremity fracture].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Nov 15;36(11):1381-1387. doi: 10.7507/1002-1892.202207096.
|
|
35360964 |
0 |
Wei M, Xu Y, Xia D, et al.
Care and Treatment for an Antiphospholipid Syndrome-Related Lower Limb Skin Ulcer Unhealed for 7 Years: A Case Report.
Int J Low Extrem Wounds. 2022 Mar 31:15347346221090079. doi: 10.1177/15347346221090079.
|
|
35298939 |
0 |
Xu Y, Gomes T, Wells PS, et al.
Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study.
Thromb Res. 2022 Feb 24;213:57-64. doi: 10.1016/j.thromres.2022.02.018.
|
|
34273241 |
0 |
Xu Y, Siegal DM.
Anticoagulant-associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants.
J Thromb Haemost. 2021 Oct;19(10):2383-2393. doi: 10.1111/jth.15466. Epub 2021 Jul 29.
|
|
33781626 |
0 |
Li Z, Chen C, Liu P, et al.
Comparison of oncological outcomes and major complications between laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IB1 cervical cancer with a tumour size less than 2 cm.
Eur J Surg Oncol. 2021 Aug;47(8):2125-2133. doi: 10.1016/j.ejso.2021.03.238. Epub 2021 Mar 22.
|
|
33289557 |
0 |
Bao HL, Ishizuka T, Yamashita A, et al.
Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2'-deoxyguanosine.
J Med Chem. 2021 Jan 14;64(1):711-718. doi: 10.1021/acs.jmedchem.0c01711. Epub 2020 Dec 8.
|
|
33078911 |
0 |
Xu Y, Siegal DM, Anand SS.
Ethnoracial variations in venous thrombosis: Implications for management, and a call to action.
J Thromb Haemost. 2021 Jan;19(1):30-40. doi: 10.1111/jth.15140. Epub 2020 Nov 20.
|
|
33075181 |
0 |
O'Brien HER, Zhang XF, Sanz-Hernandez M, et al.
Blocking von Willebrand factor free thiols inhibits binding to collagen under high and pathological shear stress.
J Thromb Haemost. 2021 Feb;19(2):358-369. doi: 10.1111/jth.15142. Epub 2020 Nov 18.
|
|
32732928 |
0 |
Ma Y, Chen F, Liu C, et al.
A novel predictive score for citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation.
Sci Rep. 2020 Jul 30;10(1):12861. doi: 10.1038/s41598-020-69902-2.
|
|
32574420 |
0 |
Xu Y, You D, Krzyzaniak H, et al.
Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta-analysis.
J Thromb Haemost. 2020 Oct;18(10):2566-2581. doi: 10.1111/jth.14977. Epub 2020 Jul 23.
|
|
32205131 |
0 |
Chen Y, Chen H, Yang J, et al.
Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy.
J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):919-929. doi: 10.1016/j.jvsv.2020.01.010. Epub 2020 Mar 21.
|
|
31434018 |
0 |
Xu Y, Schulman S, Dowlatshahi D, et al.
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.
Thromb Res. 2019 Oct;182:12-19. doi: 10.1016/j.thromres.2019.07.026. Epub 2019 Aug 2.
|
|
31216551 |
0 |
Ma Y, Chen F, Xu Y, et al.
Safety and Efficacy of Regional Citrate Anticoagulation during Plasma Adsorption Plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study.
Blood Purif. 2019;48(3):223-232. doi: 10.1159/000500408. Epub 2019 Jun 19.
|
|
30242329 |
0 |
Sholzberg M, Xu Y.
Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.
JAMA. 2018 Oct 9;320(14):1485-1486. doi: 10.1001/jama.2018.13998.
|
|
29795666 |
0 |
Xu Y, Shoamanesh A, Schulman S, et al.
Correction: Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts.
PLoS One. 2018 May 24;13(5):e0198031. doi: 10.1371/journal.pone.0198031. eCollection 2018.
|
|
29384885 |
0 |
Wang L, Xu Y, Tuo M, et al.
Recurrent stroke in a patient of lung cancer without pulmonary mass: A case report.
Medicine (Baltimore). 2018 Feb;97(5):e9815. doi: 10.1097/MD.0000000000009815.
|
|
29370183 |
0 |
Xu Y, Shoamanesh A, Schulman S, et al.
Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts.
PLoS One. 2018 Jan 25;13(1):e0191137. doi: 10.1371/journal.pone.0191137. eCollection 2018.
|
|
28612244 |
0 |
Shi J, Huang X, Li G, et al.
Cerebral venous sinus thrombosis in Behcet's disease: a retrospective case-control study.
Clin Rheumatol. 2018 Jan;37(1):51-57. doi: 10.1007/s10067-017-3718-2. Epub 2017 Jun 14.
|
|
28219635 |
0 |
Xu Y, Schulman S, Dowlatshahi D, et al.
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
Chest. 2017 Jul;152(1):81-91. doi: 10.1016/j.chest.2017.02.009. Epub 2017 Feb 17.
|
|
28103532 |
0 |
AlKherayf F, Xu Y, Westwick H, et al.
Timing of anticoagulant re-initiation following intracerebral hemorrhage in mechanical heart valves: Survey of neurosurgeons and thrombosis experts.
Clin Neurol Neurosurg. 2017 Mar;154:23-27. doi: 10.1016/j.clineuro.2017.01.006. Epub 2017 Jan 16.
|
|
27352237 |
0 |
AlKherayf F, Xu Y, Gandara E, et al.
Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: Systematic review and meta-analysis.
Thromb Res. 2016 Aug;144:152-7. doi: 10.1016/j.thromres.2016.06.014. Epub 2016 Jun 16.
|
|
26051618 |
0 |
Xu Y.
Oral Anticoagulants, Health Technology Assessment, and Health Policy.
Can J Cardiol. 2015 Aug;31(8):1074.e11. doi: 10.1016/j.cjca.2015.02.022. Epub 2015 Feb 21.
|